Mass Spectrometry Improves Osteoporosis Drug Design

Article   Oct 23, 2017

 
Mass Spectrometry Improves Osteoporosis Drug Design

Karen Steward PhD

Science Writer

 
 
 

RELATED ARTICLES

Advances in Fragment-Based Drug Discovery

Article

Over the past decade, fragment-based drug discovery has garnered increasing interest among drug discovery experts and has established itself as a key approach within the field – acting as an alternative starting point for the discovery of high-quality lead candidates. This article discusses the evolution of FBDD, highlights key drug discoveries, and explores the advantages and challenges of harnessing this approach

READ MORE

Exploiting the Tumor Microenvironment for Cancer Therapeutics

Article

It’s more than a century since Paget first proposed the ‘soil and seed’ hypothesis in cancer, providing evidence that the environment surrounding a tumor is as important as the tumor itself. Research in this area has gathered momentum and it’s now the focus of intense research efforts.

READ MORE

A Hangover Pill? Tests on drunk mice show promise

Article

Scientists create capsules filled with natural enzymes usually found in liver cells to help the body process the alcohol faster.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE